Skip to main content
Premium Trial:

Request an Annual Quote

Gen-Probe Registers $150.4M in Employee Stock Options

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Gen-Probe has filed for the registration of up to $150.4 million in additional shares in connection to a stock option being offered to all its employees.

According to the Form S-8 filed with the US Securities and Exchange Commission on Wednesday, the San Diego molecular diagnostics firm is registering 2.5 million shares at $60.14 per share. The price per share and aggregate offering price are based on the average high and low sales prices of gen-Probe's common stock on July 29.

Michael Watts, a spokesman for Gen-Probe, said the stock option plan was approved in May at the company's annual meeting.

Filed under

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.